Amantadine in Treating Cognitive & Motor Impairments in Adolescents and Adults With Cerebral Palsy

Summary

Cerebral palsy (CP) is a common childhood-onset disability associated with motor and cognitive impairments, however most research is focused on motor outcomes. The aim of this study is to determine the effects of Amantadine, a dopaminergic agonist, on cognitive function in adolescents and adults with CP.

Timeline

Start

2020-02-28

Primary completion

2022-02-22

Completion

2022-02-22

Outcome

Outcome not reported

Stopped: “PI left institution.”

Drugs

Indications